Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 23;25(24):13742.
doi: 10.3390/ijms252413742.

Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments

Affiliations

Optimizing Yeast Homologous Recombination for Splicing Large Coronavirus Genome Fragments

Guoqing Xiong et al. Int J Mol Sci. .

Abstract

Reverse genetics is a useful tool for studying viruses and developing vaccines for coronaviruses. However, constructing and manipulating the coronavirus genome in Escherichia coli can be time-consuming and challenging due to its large size and instability. Homologous recombination, a genetic manipulation mechanism found in organisms, is essential for DNA repair, gene recombination, and genetic engineering. In yeast, particularly Saccharomyces cerevisiae, homologous recombination technology is commonly used for constructing gene expression plasmids and genome editing. In this study, we successfully split and spliced a 30 kb viral genome fragment using yeast homologous recombination. By optimizing the program parameters, such as homologous arm lengths and fragment-to-vector ratios, we achieved a splicing efficiency of up to 97.9%. The optimal parameters selected were a 60 bp homologous sequence size and a vector fragment ratio of 1:2:2:2:2:2 for yeast homologous recombination of large DNA fragments.

Keywords: DNA assembly; automated splicing; reverse genetics; synthetic biology; yeast homologous recombination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The experimental operation process of this study.
Figure 2
Figure 2
Recombination efficiency of different homologous arm lengths and vector fragment ratios.
Figure 3
Figure 3
Identification of YAC plasmid. (A) PCR identification of YAC plasmid; M: 2K marker (BM101, TransGen Biotech, Beijing, China); 1–7: identification results of overlapping areas 1–7. (B) Identification results of double enzyme digested YAC plasmids; M: DNA marker (NEB, N3239S); 1: YAC plasmid with BamHI-HF (NEB, R3136M); 2: YAC plasmid with SbfI-HF (NEB, R3642S); 3: double enzyme digestion of YAC plasmid by BamHI-HF and SbfI-HF.

Similar articles

References

    1. Dong H.-L., Chen Z.-L., He M.-J., Cui J.-Z., Cheng H., Wang Q.-Y., Xiong X.-H., Liu G., Chen H.-P. The Chimeric Chaoyang-Zika Vaccine Candidate Is Safe and Protective in Mice. Vaccines. 2024;12:215. doi: 10.3390/vaccines12020215. - DOI - PMC - PubMed
    1. Polonio C.M., Peron J.P.S. ZIKV Infection and miRNA Network in Pathogenesis and Immune Response. Viruses. 2021;13:1992. doi: 10.3390/v13101992. - DOI - PMC - PubMed
    1. Zhou S., Lv P., Li M., Chen Z., Xin H., Reilly S., Zhang X. SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomed. Pharmacother. 2023;159:114242. doi: 10.1016/j.biopha.2023.114242. - DOI - PMC - PubMed
    1. Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:361–379. doi: 10.1038/s41579-023-00878-2. - DOI - PubMed
    1. Elsayed S., Bondy L., Hanage W.P. Monkeypox Virus Infections in Humans. Clin. Microbiol. Rev. 2022;35:e0009222. doi: 10.1128/cmr.00092-22. - DOI - PMC - PubMed

LinkOut - more resources